IPO registrations (S-1, F-1) · Registrants

Seagen Inc.

SEC CIK
1060736 · filings on EDGAR ↗
Name on the registration
SEATTLE GENETICS INC /WA
Former names
SEATTLE GENETICS INC /WA (2000–2020)
Registration
Form S-1, first filed 2000-11-20, last 2001-03-06; 1 initial registration, 5 amendments
Outcome
Final prospectus filed 2001-03-07
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
WA
Business address
21823 30TH DRIVE SE, SUITE, Bothell, WA 98021
EIN
91-1874389
EDGAR entity type
operating
Insiders and CEO pay
Seagen Inc. on the corporate pages

Offering terms

Proposed price range
$8.00–$10.00 per share (S-1/A filed 2001-03-06)
Final price
$7.00 per share, below the range (424B4 filed 2001-03-07, an initial public offering)
Shares sold
7,000,000
Gross proceeds
$49,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol SGEN
Lead underwriters
J.P. Morgan (2,551,429 shares); CIBC World Markets (2,232,500 shares); BofA Securities (1,594,643 shares)
Syndicate
Initial Public; Seattle Genetics; A.G. Edwards (167,857); Ragen MacKenzie Incorporated (167,857)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
2000-11-20S-1S-1 (registration)SEATTLE GENETICS INC /WA0000912057-00-050883 ↗
2000-12-05S-1/AS-1/A (amendment)SEATTLE GENETICS INC /WA0000912057-00-052268 ↗
2001-01-04S-1/AS-1/A (amendment)SEATTLE GENETICS INC /WA0000912057-01-000247 ↗
2001-02-08S-1/AS-1/A (amendment)SEATTLE GENETICS INC /WA0000912057-01-004254 ↗
2001-02-23S-1/AS-1/A (amendment)SEATTLE GENETICS INC /WA0000912057-01-006533 ↗
2001-03-06S-1/AS-1/A (amendment)SEATTLE GENETICS INC /WA0000912057-01-007273 ↗
2001-03-07424B4424B4 (final prospectus)SEATTLE GENETICS INC /WA0000912057-01-502760 ↗
2001-03-08424B4424B4 (final prospectus)SEATTLE GENETICS INC /WA0000912057-01-007391 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2001-03-06S-1/Aregistration statement$8.00–$10.007,000,000-Nasdaq SGEN5primary document; range, price table, shares headline, proceeds computed, price outside the range dropped, cover names 5document ↗
2001-03-07424B4final prospectus$7.007,000,000$49,000,000Nasdaq SGEN7primary document; price sentence, shares headline, proceeds computed, underwriting table 5, cover names 5document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
DOBMEIER ERICOfficerChief Business Officer; Chief Operating Officer; Sr. VP, Corporate Development692006–2017
ROSENBERG MORRISOfficerEVP, Development; EVP, Process Sciences; Sr. VP, Development; SVP, Development282006–2012
SIEGALL CLAY BDirector,OfficerPresident and CEO; President & CEO; See Remarks1742006–2022
SIMPSON TODD EOfficerChief Financial Officer; See Remarks742006–2023
GRYSKA DAVID WDirector492006–2023
Hoth Daniel Floyd JRDirector72006–2010
AKKARAJU SRINIVASDirector402006–2020
JP MORGAN PARTNERS BHCA LPTenPercentOwner122006–2008
J P MORGAN PARTNERS GLOBAL INVESTORS A LPTenPercentOwner82006–2008
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LPTenPercentOwner102006–2008
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LPDirector; TenPercentOwner102006–2008
JP MORGAN PARTNERS GLOBAL INVESTORS LPDirector; TenPercentOwner102006–2008
JPMP CAPITAL CORPTenPercentOwner102006–2008
JPMP GLOBAL FUND BILL BARRETT SELLDOWN LPTenPercentOwner22006
JPMP GLOBAL INVESTORS L PTenPercentOwner82006–2008
JPMP MASTER FUND MANAGER L PTenPercentOwner102006–2008
Baker Biotech Capital II (GP), LLCTenPercentOwner12006
Baker Biotech Capital III (Z) (GP), LLCTenPercentOwner12006
Baker Biotech Capital II (Z) (GP), LLCTenPercentOwner12006
Baker Brothers Life Sciences Capital (GP), LLCDirector,TenPercentOwner302006–2012
BAKER FELIXDirector; Director,Other; Director,TenPercentOwner1602006–2023
BAKER JULIANDirector; Director,Other; Director,TenPercentOwner; TenPercentOwner1532006–2023
TrailSmith Pamela AOfficerChief Scientific Officer42006–2007
BERGER FRANKLIN MDirector222006–2014
LIPPMAN MARC EDirector292006–2021
SOUTHERN DOUGLASDirector12006
14159 capital (GP), LLCDirector,TenPercentOwner262006–2011
Baker Biotech Capital (GP), LLCDirector,TenPercentOwner222006–2012
GALLEN JONATHANOther; TenPercentOwner102006–2007
DELPHI BIOINVESTMENTS VI LPTenPercentOwner12007
DELPHI MANAGEMENT PARTNERS VI LLCTenPercentOwner12007
DELPHI VENTURES VI LPTenPercentOwner12007
JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L PTenPercentOwner62007–2008
JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLPTenPercentOwner82007–2008
Baker Bros. Capital (GP), LLCDirector,TenPercentOwner122007–2012
Baker / Tisch Capital (GP), LLCDirector,TenPercentOwner72007–2012
Reynolds Thomas COfficerChief Medical Officer302007–2013
MCLAUGHLIN JOHN PETERDirector122007–2016
WELCH DANIEL GDirector352007–2023
H&Q Employee Venture Fund 2000, L.P.TenPercentOwner42008
H&Q Holdings, Inc.TenPercentOwner42008
HIMES VAUGHN BOfficerChief Technical Officer; EVP, Proc Svcs & Tech Ops; EVP, Technical Operations; EVP, Tech, Ops. & Proc. Sci.; EVP, Tech. Ops. & Proc. Sci.; See Remarks802009–2023
SEELEY BRUCE J.OfficerEVP, Commerical42009–2011
BOERNER CHRISTOPHER S.OfficerEVP, Commercial; Executive Vice President, Comm; SVP, Commercial82012–2014
Simonian Nancy ADirector162012–2023
BAKER BROS ADVISORS LLCDirector,Other; Director,TenPercentOwner572012–2023
FBB2 LLCDirector,TenPercentOwner12012
14159, L.P.Director; Director,TenPercentOwner122013–2014
667, L.P.Director; Director,Other; Director,TenPercentOwner572013–2023
Baker Brothers Life Sciences LPDirector; Director,Other; Director,TenPercentOwner572013–2023
Baker Bros. Advisors (GP) LLCDirector,Other; Director,TenPercentOwner562013–2023
DRACHMAN JONATHAN GOfficerCMO & EVP, R & D; See Remarks232013–2018
Orwin John ADirector132014–2023
LIU JEAN IOfficerChief Legal Officer; EVP, Legal Affairs & GC; GC/EVP, Leg Afairs; GC/EVP, Leg Affairs; GC & EVP, Legal Affairs; GC/EVP, Legal Affairs; See Remarks532014–2023
FBB3 LLCDirector,TenPercentOwner12014
Cline Darren SOfficerEVP, Commercial; Executive Vice President; See Remarks; SVP, Commercial282015–2018
Seth AlpnaDirector82018–2023
DANSEY ROGER DOfficerChief Medical Officer; Interim CEO & CMO; President R&D & CMO; President, R&D & CMO; President, Research and Develo; See Remarks512018–2023
TAYLOR ROBIN GOfficerChief Commercial Officer42019
ROMP CHARLES ROfficerEVP, Commercial; EVP, Commercial U.S.362020–2023
LOVE TED WDirector62020–2023
Epstein David RDirector,OfficerCEO; Chief Executive Officer52022–2023person page Fuzzy
SWAIN SANDRA MDirector42022–2023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationSEAGEN INC.WAState business registriesEIN (EXACT, as the state registration reports it)
Plan sponsorSEAGEN INC.WAForm 5500 (employee benefit plans)EIN (EXACT)
SEC filerSeagen Inc.SEC filers (EDGAR)CIK (EXACT)
Business registrationSeagen Inc.State business registriesname and state
Business registrationSeagen Inc.State business registriesname and state
Business registrationSeagen Inc.State business registriesname and state
Business registrationSeagen Inc.State business registriesname and state
Business registrationSEAGEN INC.State business registriesname and state
Business registrationSEAGEN INC.State business registriesname and state
Business registrationSEAGEN INC.State business registriesname and state
Business registrationSEAGEN INC.State business registriesname and state
Form 5500 plan sponsorSEAGEN INC.EIN (EXACT)
Federal award recipientSEAGEN INCFederal spending (USAspending)name and state
Person pageDavid R EpsteinPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), WA first:

More with this interest.

In other datasets, the same topic (Health) in WA:

Interests: Biological Products, (No Diagnostic Substances) · Health